Loomis, Sayles & Company’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-76
Closed -$8K – 775
2023
Q4
$8K Sell
76
-60
-44% -$5.54K ﹤0.01% 822
2023
Q3
$13K Buy
136
+32
+31% +$3.26K ﹤0.01% 731
2023
Q2
$10K Sell
104
-255
-71% -$23.7K ﹤0.01% 721
2023
Q1
$29K Sell
359
-102
-22% -$8.17K ﹤0.01% 688
2022
Q4
$34K Buy
461
+439
+1,995% +$34.1K ﹤0.01% 664
2022
Q3
$2K Sell
22
-70
-76% -$6.14K ﹤0.01% 788
2022
Q2
$7K Hold
92
– – ﹤0.01% 701
2022
Q1
$10K Buy
92
+19
+26% +$2.13K ﹤0.01% 710
2021
Q4
$8K Hold
73
– – ﹤0.01% 749
2021
Q3
$8K Sell
73
-24
-25% -$3.01K ﹤0.01% 864
2021
Q2
$12K Hold
97
– – ﹤0.01% 732
2021
Q1
$10K Buy
+97
New +$10.8K ﹤0.01% 777

Other funds holding DVA

Loomis, Sayles & Company's DVA Position: Q1 2024 in Review

Loomis, Sayles & Company sold out of DaVita (DVA) in Q1 2024, closing a stake of 76 shares — an estimated $8K sold.

Loomis, Sayles & Company first reported a position in DVA in Q1 2021 and held it in 12 quarters. The position peaked at $34K in Q4 2022. 545 funds tracked by Wall St. Rank hold DVA as of Q1 2024.

  • Loomis, Sayles & Company reported no remaining DaVita position as of Q1 2024 after selling out during the quarter.
  • Loomis, Sayles & Company sold 76 DaVita shares in Q1 2024, an estimated $8K.
  • Loomis, Sayles & Company first reported a position in DaVita in Q1 2021 and held it in 12 quarters.
  • Loomis, Sayles & Company's DaVita position peaked at $34K in Q4 2022.
  • 545 funds tracked by Wall St. Rank held DaVita as of Q1 2024.

Based on Loomis, Sayles & Company's 13F filing for Q1 2024, filed 14 May 2024.